World's Best Scientists 2026 revealed!
Elizabeth A. Eisenhauer

Elizabeth A. Eisenhauer

D-Index & Metrics

Medicine

D-Index
88
Citations
112994
World Ranking
12874
National Ranking
526

Overview

Elizabeth A. Eisenhauer is affiliated with Queen's University in Canada. Their research spans the intersection of medicine, economics, econometrics, and finance, with a total of 51 publications in Medicine and 22 in Economics, Econometrics and Finance.

Their subfields of study include Economics and Econometrics, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, and Statistics and Probability. Their research topics cover Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations and Quality of Life, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Statistical Methods in Clinical Trials, and Global Cancer Incidence and Screening.

Elizabeth A. Eisenhauer has published multiple papers in notable venues. Frequent publication venues include JAMA Oncology, The Lancet Oncology, European Journal of Cancer, Current Oncology, and CHEST Journal.

Some recent publications include:

  • Evolution of the Randomized Clinical Trial in the Era of Precision Oncology, 2021, JAMA Oncology
  • Common Sense Oncology: outcomes that matter, 2023, The Lancet Oncology
  • Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer, 2023, European Journal of Cancer
  • Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug Class, 2022, JAMA Oncology
  • Medical students need artificial intelligence and machine learning training, 2021, Nature Biotechnology

Elizabeth has collaborated frequently with a group of coauthors, with the highest number of joint publications involving Bishal Gyawali and Christopher M. Booth, each having 14 coauthored works. Other frequent collaborators include Michael Brundage, Ian F. Tannock, and Brooke E. Wilson.

Best Publications

  • New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

    Elizabeth Eisenhauer;Patrick Therasse;Jan Bogaerts;L.H. Schwartz

  • Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

    Roger Stupp;Warren P. Mason;Martin J. van den Bent;Michael Weller

  • New guidelines to evaluate the response to treatment in solid tumors

    Patrick Therasse;Susan G. Arbuck;Elizabeth A. Eisenhauer;Jantien Wanders

  • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

    Roger Stupp;Monika E. Hegi;Warren P. Mason;Martin J. van den Bent

  • Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.

    Jacobus Pfisterer;Marie Plante;Ignace Vergote;Andreas du Bois

  • Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

    Edward L. Korn;Ping Yu Liu;Sandra J. Lee;Judith Anne W. Chapman

  • European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.

    E A Eisenhauer;W W ten Bokkel Huinink;K D Swenerton;L Gianni

  • Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis.

    Astec;P Blake;Ann Marie Swart

  • Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

    Gordon John Sampson Rustin;Ignace Vergote;Elizabeth Eisenhauer;Eric Pujade-Lauraine

  • Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

    Thierry Gorlia;Martin J van den Bent;Monika E Hegi;Monika E Hegi;René O Mirimanoff

  • 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

    A du Bois;M Quinn;T Thigpen;J Vermorken

  • Measuring Response in Solid Tumors: Unidimensional Versus Bidimensional Measurement

    Keith James;Elizabeth Eisenhauer;Michaele Christian;Monica Terenziani

  • Advanced epithelial ovarian cancer: 1998 consensus statements.

    J. S. Berek;K. Bertelsen;A. Du Bois;M. F. Brady

  • Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)

    Gordon J. S. Rustin;Michael Quinn;Tate Thigpen;Andreas du Bois

  • Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

    Amit M. Oza;Laurie Elit;Ming-Sound Tsao;Suzanne Kamel-Reid

  • Progression-Free Survival: Meaningful or Simply Measurable?

    Christopher M. Booth;Elizabeth A. Eisenhauer

  • Health-related quality of life in patients with glioblastoma: a randomised controlled trial

    Martin J B Taphoorn;Roger Stupp;Corneel Coens;David Osoba

  • Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patients

    E. A. Eisenhauer;J. B. Vermorken;M. van Glabbeke

  • The taxoids. Comparative clinical pharmacology and therapeutic potential.

    Elizabeth A. Eisenhauer;Jan B. Vermorken

  • European-Canadian randomized trial of Paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

    Elizabeth A. Eisenhauer;Wim W. ten Bokkel Huinink;Kenneth D. Swenerton;Luca Gianni

Frequent Co-Authors

Dongsheng Tu
Dongsheng Tu Queen's University
Amit M. Oza
Amit M. Oza Princess Margaret Cancer Centre
Kim N. Chi
Kim N. Chi BC Cancer Agency
Lesley Seymour
Lesley Seymour Queen's University
Suzanne Kamel-Reid
Suzanne Kamel-Reid University Health Network
Janet Dancey
Janet Dancey Queen's University
Ming-Sound Tsao
Ming-Sound Tsao Princess Margaret Cancer Centre
Jan B. Vermorken
Jan B. Vermorken University of Antwerp
Kathleen I. Pritchard
Kathleen I. Pritchard University of Toronto
Jeremy A. Squire
Jeremy A. Squire Universidade de São Paulo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine also opens doors to many related fields through flexible online study options. For those interested in the business side of healthcare, a healthcare administration degree online accredited program can lead to leadership or management roles in hospitals and clinics.

Registered nurses aiming for advanced practice can benefit from specialized bridge programs, such as rn to fnp bridge programs. These programs make it possible to become a family nurse practitioner, enhancing both clinical skills and earning potential.

With public interest in wellness and preventive care rising, online degrees in nutrition offer a route to professional roles in dietetics, health education, and research.

If you are drawn to high-level leadership in the healthcare industry, online mha programs cahme accredited allow you to earn a respected qualification needed for executive and administrative positions.

Each pathway provides the opportunity to impact patient care and healthcare systems—even outside traditional medical practice—while offering the convenience and flexibility of online learning.

Best Scientists Citing Elizabeth A. Eisenhauer

Trending Scientists

Recently Published Articles